Evidence map›Paper›PMID 35521215›Full record

ArticleFrontiers in cellular and infection microbiology2022

Microbiota Associated With Cholesteatoma Tissue in Chronic Suppurative Otitis Media.

Daniel N Frank, Jose Pedrito M Magno, Karen Joyce S Velasco, Tori C Bootpetch, Jacob Ephraim D Salud, Kevin Jer V David, Aaron L Miller, Eljohn C Yee, Heather P Dulnuan, Richard B Pyles and 14 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. A NovelInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 2 countries.

Daniel N FrankDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Jose Pedrito M MagnoDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Karen Joyce S VelascoDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Tori C BootpetchDepartment of Otolaryngology-Head and Neck Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Jacob Ephraim D SaludDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Kevin Jer V DavidDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Aaron L MillerDepartment of Pediatrics, University of Texas Medical Branch, Galveston, TX, United States.
Eljohn C YeeDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Heather P DulnuanDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Richard B PylesDepartment of Pediatrics, University of Texas Medical Branch, Galveston, TX, United States.
Jan Alexeis C LacuataDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Jeric L ArbizoDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Jennifer M KofonowDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Beatrice GuceDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Kevin Michael D MendozaDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Charles E RobertsonDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Gabriel Martin S IlustreDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Alessandra Nadine E ChiongDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Shi-Long LuDepartment of Otolaryngology-Head and Neck Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Erik A TongolDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Nicole D SacayanDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Talitha Karisse L YarzaPhilippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
Charlotte M ChiongDepartment of Otolaryngology - Head and Neck Surgery, University of the Philippines College of Medicine - Philippine General Hospital, Manila, Philippines.
Regie Lyn P Santos-CortezDepartment of Otolaryngology-Head and Neck Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Philippine General Hospital · PHUniversity of Colorado Anschutz Medical Campus · USThe University of Texas Medical Branch at Galveston · USUniversity of the Philippines Manila · PH

Funding

Otitis Media Susceptibility and Middle Ear Microbial Shifts due to Gene VariantsR01DC015004 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI SANTOS-CORTEZ, REGIE LYN PASTOR · 2016 to 2020
$1.9M
NIDCD NIH HHS R01 DC015004
6 · The paper itself

Abstract

Otitis media (OM), defined as infection or inflammation of the middle ear (ME), remains a major public health problem worldwide. Cholesteatoma is a non-cancerous, cyst-like lesion in the ME that may be acquired due to chronic OM and cause disabling complications. Surgery is required for treatment, with high rates of recurrence. Current antibiotic treatments have been largely targeted to previous culturable bacteria, which may lead to antibiotic resistance or treatment failures. For this study, our goal was to determine the microbiota of cholesteatoma tissue in comparison with other ME tissues in patients with long-standing chronic OM. ME samples including cholesteatoma, granulation tissue, ME mucosa and discharge were collected from patients undergoing tympanomastoidectomy surgery for chronic OM. Bacteria were profiled by 16S rRNA gene sequencing in 103 ME samples from 53 patients. Respiratory viruses were also screened in 115 specimens from 45 patients. Differences in bacterial profiles (beta-diversity) and the relative abundances of individual taxa were observed between cholesteatoma and ME sample-types. Additionally, patient age was associated with differences in overall microbiota composition while numerous individual taxa were differentially abundant across age quartiles. No viruses were identified in screened ME samples. Biodiversity was moderately lower in cholesteatoma and ME discharge compared to ME mucosal tissues. We also present overall bacterial profiles of ME tissues by sample-type, age, cholesteatoma diagnosis and quinolone use, including prevalent bacterial taxa. Our findings will be useful for fine-tuning treatment protocols for cholesteatoma and chronic OM in settings with limited health care resources.

Indexed as

CholesteatomaMicrobiotaOtitis MediaOtitis Media, SuppurativeBacteriaChronic DiseaseHumansPersistent InfectionRNA, Ribosomal, 16SRNA, Ribosomal, 16S16S rRNAcholesteatomamicrobiomemiddle earotitis media

Identifiers

PMID35521215
PMCPMC9063009
OpenAlexW4224238153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.